Dublin, Oct. 19, 2017 -- The "Global Advanced Wound Care Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.
In this region, global advanced wound care is projected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.
Some of the major factors driving the growth of advanced wound care market are rising aging population, growing incidences of diabetes, technological advancement.
Scope of the Report
- Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing. In 2017, film dressing segment is expected to dominate the global advanced wound care market.
- Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.
- Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).
- Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies.
- Based on NPWT type, the market is segmented into stand-alone NPWT devices, portable NPWT devices and disposable NPWT devices.
- Based on PRD type, the market is segmented into mattress and bed.
- Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.
- Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.
- Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.
- Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, venous ulcer among others. Diabetic ulcers segment is expected to grow at the highest CAGR of in the forecast period.
- On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
- On the basis of distribution channel the market is segmented into direct tenders, and retails.
Acelity L.P. INC. is going to dominate the Advanced Wound Care market followed by
- 3M
- Advancis Medical
- B.Braun Melsungen AG
- Baxter
- BSN Medical
- Cardinal Health
- Coloplast
- Convatec Inc
- Derma Sciences Inc
- DermaRite Industries LLC
- DeRoyal Industries Inc
- Devon Medical Products
- Ethicon. Inc
- Hollister Inc
- Human Biosciences Inc
- Integra Life Sciences Corporation
- Kinetic Concepts
- Medline Industries
- Medtronic
- Mimedx Group
- Molnlycke Healthcare AB
- MPM Medical Inc
- Organogenesis Inc
- Paul Hartmann Limited
- Smith and Nephew
- Spiracur Inc
- Talley Group
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
3.1. Drivers
3.1.1. Rising Aging and Geriatric Population
3.1.2. Technological Advancement
3.1.3. Government Support
3.1.4. Rising Incidences of Chronic Wound
3.1.5. Increasing Trend
3.2. Restraints
3.2.1. Low Awareness
3.2.2. Slow Growth Rate and Shrinking Market
3.2.3. Complex Regulatory Approval Process
3.2.4. Competition With Other Moist Dressings
3.3. Opportunities
3.3.1. Reimbursement
3.3.2. Mergers and Acquisitions To Expand Business
3.3.3. Unmet Need
3.3.4. Increasing Demand
3.4. Challenge
3.4.1. Shortage of Trained Staff
3.4.2. The Development of Substitute Products
3.5. Key Market Trends and Upcoming Technologies
3.5.1. Smart Dressing Will Push Future Growth
3.5.2. Hydrofiber Has Been the Most Significant Recent Innovation
3.5.3. Alginate Dressing is Expected To Grow Robustly in the Upcoming Years
3.5.4. Foam Dressing Accounting the Largest Market Segment in the Upcoming Years
4. Executive Summary
5. Premium Insights
6. Global Advanced Wound Care Market, by Product Type
6.1. Overview
6.2. Dressing
6.3. Biologics
6.4. Therapy Devices
7. Global Advanced Wound Care Market, by Wound Type
7.1. Introduction
7.2. Surgical Wound
7.2.1. Class I
7.2.2. Class II
7.2.3. Class III
7.2.4. Class IV
7.3. Diabetic Ulcers
7.4. Pressure Ulcers
7.5. Venous Ulcers
7.6. Burns
8. Global Advanced Wound Care Market, by End User
9. Global Advanced Wound Care Market, by Distribution Channel
10. Global Advanced Wound Care Market, by Geography
11. Global Advanced Wound Care Market, Company Share
12. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/7zvslt/global_advanced
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Wound Care


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Instagram Outage Disrupts Thousands of U.S. Users
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



